Futura Medical is an Aim-listed pharmaceuticals tiddler, with only 14 staff and directors, which sells a single, brand-new gel. It works out of a small Surrey University science park, and its share price has surged by 84 per cent since last year. So it’s not the obvious contender for a share tip.
However, Futura has made a new product that works, and it is only just starting to shout about it. The company’s Eroxon gel is the first erectile dysfunction gel approved to go on sale without a prescription. It is already available at Boots and online via the likes of Amazon, and it is the first new ED gel for two decades. Clinical trials showed Eroxon successfully pumped up 65 per cent of users.